BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 3,443.55% | 3,565.17% | 3,565.17% | 1,139.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 3,443.55% | 3,565.17% | 3,565.17% | 1,139.39% |
| Cost of Revenue | -- | 1,333.70% | 936.08% | 936.08% | 381.60% |
| Gross Profit | -- | 3,752.00% | 4,170.02% | 4,170.02% | 1,274.32% |
| SG&A Expenses | -- | 1,079.64% | 769.51% | 769.52% | 398.66% |
| Depreciation & Amortization | -- | -6.33% | -8.27% | -9.03% | -5.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 1,058.90% | 750.75% | 750.75% | 384.80% |
| Operating Income | -- | 297.47% | 201.01% | 201.02% | 88.87% |
| Income Before Tax | -- | 266.30% | 179.67% | 179.68% | 65.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | 216.65% | 148.14% | 148.14% | 51.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 217.13% | 148.75% | 148.75% | 50.78% |
| EBIT | -- | 297.47% | 201.01% | 201.02% | 88.87% |
| EBITDA | -- | 303.91% | 205.35% | 205.34% | 91.54% |
| EPS Basic | -- | 192.82% | 134.95% | 134.97% | 49.29% |
| Normalized Basic EPS | -- | 247.41% | 172.84% | 172.84% | 77.59% |
| EPS Diluted | -- | 168.02% | 116.83% | 120.65% | 43.66% |
| Normalized Diluted EPS | -- | 212.02% | 147.99% | 152.78% | 70.63% |
| Average Basic Shares Outstanding | -- | 21.60% | 20.37% | 20.37% | 18.06% |
| Average Diluted Shares Outstanding | -- | 45.99% | 44.24% | 36.20% | 24.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |